Effectiveness of Integrated Neurocognitive Therapy on Cognitive Impairment and Functional Outcome for Schizophrenia Outpatients

Andreana De Mare, Miriam Cantarella, Giovanni Galeoto, Andreana De Mare, Miriam Cantarella, Giovanni Galeoto

Abstract

Cognitive impairment is highly prevalent in patients with schizophrenia and schizoaffective disorder. Many interventions have been developed to treat cognitive deficit, since it has a strong impact on functional outcome; however, there are no integrated interventions targeting multiple neuro- and social-cognitive domains with a particular focus on the generalization of the effects of therapy on the functional outcome. Recently, a group of experts has developed a cognitive remediation group therapy approach called Integrated Neurocognitive Therapy (INT), which includes exercises to improve the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) neuro- and social-cognitive domains. This systematic review and meta-analysis aimed to assess the efficacy of this approach. We conducted a search of PubMed, Scopus, Web of Science, and PsycINFO to select primary studies evaluating INT in schizophrenic and schizoaffective patients. The primary outcomes of the meta-analysis included negative and positive symptoms and global functioning. Two randomized controlled trials met inclusion criteria. A total of 217 participants were included. Based on the results from the Positive and Negative Syndrome Scale (PANSS), a significant pooled effect size was observed for negative symptoms, which demonstrated not only an improvement in the patients treated immediately after therapy but also a permanence of positive results at a 9-12-month follow-up. On the other hand, no significant effect size was observed for positive symptoms. In addition, a significant pooled effect size was found for Global Assessment of Functioning (GAF), which shows how INT's integrated approach has lasting positive implications on patients' functional outcome. We concluded that INT might be an effective treatment for negative symptoms and global functioning in patients with schizophrenia, compared to treatment as usual (TAU).

Figures

Figure 1
Figure 1
Flow-chart.
Figure 2
Figure 2
Quality appraisal. + (green), low risk of bias; ? (yellow), unclear risk of bias; − (red), high risk of bias.
Figure 3
Figure 3
Figure 4
Figure 4
Figure 5
Figure 5

References

    1. Tripathi A., Kar S. K., Shukla R. Cognitive deficits in schizophrenia: Understanding the biological correlates and remediation strategies. Clinical Psychopharmacology and Neuroscience. 2018;16(1):7–17. doi: 10.9758/cpn.2018.16.1.7.
    1. Keefe R. S. E., Eesley C. E., Poe M. P. Defining a cognitive function decrement in schizophrenia. Biological Psychiatry. 2005;57(6):688–691. doi: 10.1016/j.biopsych.2005.01.003.
    1. Heinrichs R. W., Zakzanis K. K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12(3):426–445. doi: 10.1037/0894-4105.12.3.426.
    1. Woodberry K. A., Giuliano A. J., Seidman L. J. Premorbid IQ in schizophrenia: A meta-analytic review. The American Journal of Psychiatry. 2008;165(5):579–587. doi: 10.1176/appi.ajp.2008.07081242.
    1. Aylward E., Walker E., Bettes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophrenia Bulletin. 1984;10(3):430–459. doi: 10.1093/schbul/10.3.430.
    1. Marder S. R., Fenton W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophrenia Research. 2004;72(1):5–9. doi: 10.1016/j.schres.2004.09.010.
    1. Nuechterlein K. H., Barch D. M., Gold J. M., Goldberg T. E., Green M. F., Heaton R. K. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 2004;72(1):29–39. doi: 10.1016/j.schres.2004.09.007.
    1. Bon L., Franck N. The impact of cognitive remediation on cerebral activity in schizophrenia: Systematic review of the literature. Brain and Behavior. 2018;8(3)
    1. Vita A., Barlati S., Bellani M., Brambilla P. Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives. Epidemiology and Psychiatric Sciences. 2014;23(1):21–25. doi: 10.1017/s2045796013000541.
    1. Kubicki M., McCarley R., Westin C.-F., et al. A review of diffusion tensor imaging studies in schizophrenia. Journal of Psychiatric Research. 2007;41(1-2):15–30. doi: 10.1016/j.jpsychires.2005.05.005.
    1. Medalia A., Choi J. Cognitive remediation in schizophrenia. Neuropsychology Review. 2009;19(3):353–364. doi: 10.1007/s11065-009-9097-y.
    1. McGurk S. R., Twamley E. W., Sitzer D. I., McHugo G. J., Mueser K. T. A meta-analysis of cognitive remediation in schizophrenia. The American Journal of Psychiatry. 2007;164(12):1791–1802. doi: 10.1176/appi.ajp.2007.07060906.
    1. Wykes T., Huddy V., Cellard C., McGurk S. R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. The American Journal of Psychiatry. 2011;168(5):472–485. doi: 10.1176/appi.ajp.2010.10060855.
    1. Schmidt S. J., Mueller D. R., Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: Empirical review and new results by structural equation modeling. Schizophrenia Bulletin. 2011;37(2):S41–S54. doi: 10.1093/schbul/sbr079.
    1. Wykes T., Huddy V. Cognitive remediation for schizophrenia: It is even more complicated. Current Opinion in Psychiatry. 2009;22(2):161–167. doi: 10.1097/YCO.0b013e328322fbf4.
    1. Mueller D. R., Schmidt S. J., Roder V. One-year randomized controlled trial and follow-up of integrated neurocognitive therapy for schizophrenia outpatients. Schizophrenia Bulletin. 2015;41(3):604–616. doi: 10.1093/schbul/sbu223.
    1. Kurtz M. M., Richardson C. L. Social cognitive training for schizophrenia: A meta-analytic investigation of controlled research. Schizophrenia Bulletin. 2012;38(5):1092–1104. doi: 10.1093/schbul/sbr036.
    1. Mueller D. R., Khalesi Z., Benzing V., Castiglione C. I., Roder V. Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients? Schizophrenia Research. 2017;188:92–97. doi: 10.1016/j.schres.2017.01.037.
    1. Mueller D. R., Schmidt S. J., Roder V. Integrated psychological therapy: Effectiveness in schizophrenia inpatient settings related to patients' age. The American Journal of Geriatric Psychiatry. 2013;21(3):231–241. doi: 10.1016/j.jagp.2012.12.011.
    1. Vita A., et al. INT- Terapia Neurocognitiva Integrata nel trattamento della schizofrenia. Springer; 2015.
    1. Higgins J. P. T., Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011. .
    1. Marquez M. A., De Santis R., Ammendola V., et al. Cross-cultural adaptation and validation of the “Spinal Cord Injury-Falls Concern Scale” in the Italian population. Spinal Cord. 2018;56(7):712–718. doi: 10.1038/s41393-018-0070-6.
    1. Galeoto G., Colalelli F., Massai P., et al. Quality of life in Parkinson’s disease: Italian validation of the Parkinson’s Disease Questionnaire (PDQ-39-IT) Neurological Sciences. doi: 10.1007/s10072-018-3524-x.
    1. Covotta A., Gagliardi M., Berardi A., et al. Physical Activity Scale for the Elderly: Translation, Cultural Adaptation, and Validation of the Italian Version. Current Gerontology and Geriatrics Research. 2018;2018:1–7. doi: 10.1155/2018/8294568.
    1. Galeoto G., Sansoni J., Scuccimarri M., et al. A Psychometric Properties Evaluation of the Italian Version of the Geriatric Depression Scale. Depression Research and Treatment. 2018;2018
    1. Murgia M., Bernetti A., Delicata M., Massetti C., Achilli E. M., Mangone M. Inter-and intra-interviewer reliability of Italian version of Pediatric Evaluation of Disability Inventory. Ann Ig. 2018;30:153–161.
    1. Berardi A., De Santis R., Tofani M., et al. The Wheelchair Use Confidence Scale: Italian translation, adaptation, and validation of the short form. Disability and Rehabilitation: Assistive Technology. 2017;13(6):575–580. doi: 10.1080/17483107.2017.1357053.
    1. Tofani M., Candeloro C., Sabbadini M., et al. The psychosocial impact of assistive device scale: Italian validation in a cohort of nonambulant people with neuromotor disorders. Assistive Technology. 2018:1–6. doi: 10.1080/10400435.2018.1469553.
    1. Galeoto G., Berardi A., De Santis R., et al. Validation and cross-cultural adaptation of the Van Lieshout test in an Italian population with cervical spinal cord injury: a psychometric study. Spinal Cord Series and Cases. 2018;4(1) doi: 10.1038/s41394-018-0083-6.
    1. Dattoli S., Colucci M., Soave M. G., et al. Evaluation of pelvis postural systems in spinal cord injury patients: Outcome research. The Journal of Spinal Cord Medicine. 2018:1–13. doi: 10.1080/10790268.2018.1456768.
    1. Attanasio G., Camerota F., Ralli M., et al. Does focal mechanical stimulation of the lower limb muscles improve postural control and sit to stand movement in elderly? Aging Clinical and Experimental Research. 2018;30(10):1161–1166. doi: 10.1007/s40520-018-0909-x.
    1. Massai P., Colalelli F., Sansoni J., et al. Reliability and Validity of the Geriatric Depression Scale in Italian Subjects with Parkinson’s Disease. Parkinson’s Disease. 2018;2018:1–6. doi: 10.1155/2018/7347859.
    1. Galeoto G., Sili A., Tamburlani M., et al. Construction and validation of a tool for the evaluation of environmental risks and limitations to the manual handling of loads: Cross-sectional study. La Clinica Terapeutica. 2017;168(6):e349–e356.
    1. Castiglia S. The culturally adapted Italian version of the Barthel Index (IcaBI): assessment of structural validity, inter-rater reliability and responsiveness to clinically relevant improvements in patients admitted to inpatient rehabilitation centers. Functional Neurology. 2017;32(4):p. 221. doi: 10.11138/FNeur/2017.32.4.221.
    1. Parente M., Tofani M., De Santis R., Esposito G., Santilli V., Galeoto G. The Role of the Occupational Therapist in Disaster Areas: Systematic Review. Occupational Therapy International. 2017;2017:8. doi: 10.1155/2017/6474761.6474761
    1. Culicchia G., Nobilia M., Asturi M., Santilli V., Paoloni M., De Santis R., et al. Rehabil Res Pract. 2016; 2016. Cross-Cultural Adaptation and Validation of the Jebsen-Taylor Hand Function Test in an Italian Population; p. p. 2016.
    1. Migliorini R., Comberiati A. M., Galeoto G., Fratipietro M., Arrico L. Eye motility alterations in retinitis pigmentosa. Journal of Ophthalmology. 2015;2015:6. doi: 10.1155/2015/145468.145468

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere